Safety and Efficacy Study of AL-53817 and AL-78843 Ophthalmic Solutions for Allergic Conjunctivitis

NCT02079649 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

224

Enrollment

INDUSTRY

Sponsor class

Conditions

Allergic Conjunctivitis

Interventions

DRUG: AL-53817 Ophthalmic Solution, 0.1%
DRUG: AL-78843 Ophthalmic Solution, 0.03%
DRUG: Dexamethasone Ophthalmic Suspension, 0.1%
DRUG: AL-53817 Vehicle

Sponsor

Alcon Research